vTv Therapeutics Inc. - (VTVT): Price and Financial Metrics
vTv Therapeutics Inc. - (VTVT)
Today's Latest Price: $1.75 USD
Updated Sep 25 4:00pm
Add VTVT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
VTVT Stock Summary
- With a price/sales ratio of 5,406.22, vTv Therapeutics Inc has a higher such ratio than 99.8% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, vTv Therapeutics Inc is reporting a growth rate of 264.7%; that's higher than 94.81% of US stocks.
- As for revenue growth, note that VTVT's revenue has grown -99.78% over the past 12 months; that beats the revenue growth of only 0.47% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to vTv Therapeutics Inc are AUPH, VNRX, AIMT, MRTX, and RVNC.
- VTVT's SEC filings can be seen here. And to visit vTv Therapeutics Inc's official web site, go to www.vtvtherapeutics.com.
VTVT Stock Price Chart Technical Analysis Charts
VTVT Price/Volume Stats
| Current price | $1.75 | 52-week high | $4.23 |
| Prev. close | $1.73 | 52-week low | $1.35 |
| Day low | $1.70 | Volume | 266,943 |
| Day high | $1.78 | Avg. volume | 597,720 |
| 50-day MA | $2.21 | Dividend yield | N/A |
| 200-day MA | $2.31 | Market Cap | 124.34M |
vTv Therapeutics Inc. - (VTVT) Company Bio
vTv Therapeutics Inc., a biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates worldwide. The company was founded in 2015 and is based in High Point, North Carolina.
Loading social stream, please wait...